Chang, David K., Jamieson, Nigel B., Nagrial, Adnan M., Chantrill, Lorraine A., Chin, Venessa T., Pinho, Andreia V., Rooman, Ilse, Cowley, Mark J., Wu, Jianmin, Mead, R. Scott, Colvin, Emily K., Samra, Jaswinder S., Johns, Amber L., Corbo, Vincenzo, Bassi, Claudio, Falconi, Massimo, Lawlor, Rita T., Crippa, Stefano, Sperandio, Nicola, Bersani, Samantha, Dickson, Euan J., Mohamed, Mohamed A. A., Oien, Karin A., Scarlett, Christopher J., Foulis, Alan K., Musgrove, Elizabeth A., Sutherland, Robert L., Kench, James G., Carter, C. Ross, Gill, Anthony J., Scarpa, Aldo, McKay, Colin J., Biankin, Andrew V., Pajic, Marina, Chou, Angela, Pinese, Mark, Humphris, Jeremy L., Jones, Marc D., Toon, Christopher. American Society of Clinical Oncology; 2013. Histomolecular phenotypes and outcome in adenocarcinoma of the ampulla of Vater.

Biankin, Andrew V., Waddell, Nicola, Chang, David K., Cowley, Mark J., Gardiner, Brooke B., Song, Sarah, Harliwong, Ivon, Idrisoglu, Senel, Nourse, Craig, Nourbakhsh, Ehsan, Manning, Suzanne, Wani, Shivangi, Kassahn, Karin S., Gongora, Milena, Pajic, Marina, Scarlett, Christopher J., Gill, Anthony J., Pinho, Andrei V., Rooman, Ilse, Anderson, Matthew, Holmes, Oliver, Leonard, Conrad, Taylor, Darrin, Gingras, Marie-Claude, Wood, Scott, Xu, Qinying, Nones, Katia, Fink, J. Lynn, Christ, Angelika, Bruxner, Tim, Cloonan, Nicole, Kolle, Gabriel, Newell, Felicity, Pinese, Mark, Muthuswamy, Lakshmi B., Mead, R. Scott, Humphris, Jeremy L., Kaplan, Warren, Jones, Marc D., Colvin, Emily K., Nagrial, Adnan M., Humphrey, Emily S., Chou, Angela, Chin, Venessa T., Chantrill, Lorraine A., Johns, Amber L., Mawson, Amanda, Samra, Jaswinder S., Kench, James G., Lovell, Jessica A., Daly, Roger J., Merrett, Neil D., Toon, Christopher, Epari, Krishna, Nguyen, Nam Q., Barbour, Andrew, Miller, David K., Zeps, Nikolajs, Kakkar, Nipun, Zhao, Fengmei, Qing Wu, Yuan, Wang, Min, Muzny, Donna M., Fisher, William E., Brunicardi, F. Charles, Hodges, Sally E., Reid, Jeffrey G., Wilson, Peter J., Drummond, Jennifer, Chang, Kyle, Han, Yi, Lewis, Lora R., Dinh, Huyen, Buhay, Christian J., Beck, Timothy, Timms, Lee, Sam, Michelle, Begley, Kimberly, Patch, Ann-Marie, Brown, Andrew, Pai, Deepa, Panchal, Ami, Buchner, Nicholas, De Borja, Richard, Denroche, Robert E., Yung, Christina K., Serra, Stefano, Onetto, Nicole, Mukhopadhyay, Debabrata, Wu, Jianmin, Tsao, Ming-Sound, Shaw, Patricia A., Petersen, Gloria M., Gallinger, Steven, Hruban, Ralph H., Maitra, Anirban, Iacobuzio-Donahue, Christine A., Schulick, Richard D., Wolfgang, Christopher L., Morgan, Richad A.. Nature Publishing Group; 2012. Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes.

Humphris, Jeremy L., Johns, Amber L., Mead, R. Scott, Gill, Anthony J., Samra, Jaswinder S., Kench, James G., Musgrove, Elizabeth A., Tucker, Katherine M., Spigelman, Allan D., Waddell, Nic, Grimmond, Sean M., Biankin, Andrew V. Biankin, Simpson, Skye H., Australian Pancreatic Cancer Genome Initiative,, Cowley, Mark J., Pajic, Marina, Chang, David K., Nagrial, Adnan M., Chin, Venessa T., Chantrill, Lorraine A., Pinese, Mark. Wiley-Blackwell Publishing; 2014. Clinical and pathologic features of familial pancreatic cancer.

Susanto, Johana M., Colvin, Emily K., Biankin, Andrew V., Scarlett, Christopher J., Pinese, Mark, Chang, David K., Pajic, Marina, Mawson, Amanda, Caldon, C. Elizabeth, Musgrove, Elizabeth A., Henshall, Susan M., Sutherland, Robert L.. Spandidos Publications; 2015. The epigenetic agents suberoylanilide hydroxamic acid and 5-AZA-2' deoxycytidine decrease cell proliferation, induce cell death and delay the growth of MiaPaCa2 pancreatic cancer cells in vivo.

Humphris, Jeremy L., Patch, Ann-Marie, Quinn, Michael C. J., Bruxner, Timothy J. C., Christ, Angelika N., Harliwong, Ivon, Idrisoglu, Senel, Manning, Suzanne, Nourse, Craig, Nourbakhsh, Ehsan, Stone, Andrew, Wilson, Peter J., Nones, Katia, Scarlett, Christopher J., , , , , , , , , , Bailey, Peter J., , , , , , , , , , , Johns, Amber L., , , , , , , , , , , McKay, Skye, , , , , , , , , , , Chang, David K., , , , , , , , , , , Miller, David K., , , , , , , , , , , Pajic, Marina, , , , , , Kassahn, Karin S.. W. B. Saunders; 2017. Hypermutation in pancreatic cancer.

Waddell, Nicola, Pajic, Marina, Quinn, Michael C. J., Robertson, Alan J., Fadlullah, Muhammad Z. H., Bruxner, Tim J. C., Christ, Angelika N., Harliwong, Ivon, Idrisoglu, Senel, Manning, Suzanne, Nourse, Craig, Nourbakhsh, Ehsan, Patch, Ann-Marie, Scarlett, Christopher J., , , , , , , , , , Chang, David K., , , , , , , , , , , Kassahn, Karin S., , , , , , , , , , , Bailey, Peter, , , , , , , , , , , Johns, Amber L., , , , , , , , , , , Miller, David, , , , , , , , , , , Nones, Katia, , , , , , , , , , , Quek, Kelly. Nature Publishing Group; 2015. Whole genomes redefine the mutational landscape of pancreatic cancer.